IP Library Granted Patent US 8,877,510
Granted Patent B2
US 8,877,510 · App. 14/087,823 · Granted Nov 4, 2014

Method for conducting platelet aggregation analysis

Inventors: Andreas Calatzis (Munich, DE); Ben Krüger (Munich, DE); Marc Wittwer (Munich, DE)
Assignee: F. Hoffmann-La Roche AG
G01N33/86G01N33/4905G01N27/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,510
App. No.
14/087,823
Granted
Nov 4, 2014
Kind
B2
Abstract

A cartridge device having a receiving portion for receiving a blood sample and a jack portion for receiving a plug; a stirring device for circulating the blood sample within the receiving portion; and an electrode holder having at least one incorporated electrode wire pair; wherein the electrode holder is attachable to the cell such that one end of the at least one electrode wire pair forms a sensor unit for measuring the electrical impedance between the two electrode wires of the at least one electrode wire pair within the blood sample and that the opposite end of the at least one electrode wire pair forms a plug portion being connectable directly to the plug for an electrical connection of the sensor unit to an analyzer.

Claims (13)

1. A method for conducting platelet aggregation analysis, comprising:

(a) placing a blood sample in a cup portion of a cartridge device, wherein the cartridge device includes at least three electrodes and the at least three electrodes are immersed in the blood sample;

(b) stirring the blood sample to circulate the blood sample within the cup portion of the cartridge device;

(c) measuring impedance signals between the at least three electrodes to provide at least a first impedance signal measured between a first one of the at least three electrodes and a second one of the at least three electrodes, a second impedance signal measured between the second one of the at least three electrodes and a third one of the at least three electrodes, and a third impedance signal measured between the first one of the at least three electrodes and the third one of the at least three electrodes;

(d) comparing the first impedance signal, the second impedance signal and the third impedance signal to a mean or median of the first, second and third impedance signals to determine if a variation for one of the first impedance signal, the second impedance signal and the third impedance signal is higher than a first predetermined threshold;

(e) discarding one of the first impedance signal, the second impedance signal or the third impedance signal if the variation from the mean or median of first impedance signal, the second impedance signal or the third impedance signal is higher than the first predetermined threshold, respectively;

(f) comparing a remaining pair of impedance signals of the first impedance signal, the second impedance signal and the third impedance signal if one of the first impedance signal, the second impedance signal or the third impedance signal was discarded in step (e) in order to determine if a variation between two signals comprising the remaining pair of impedance signals is higher than a second predetermined threshold; and,

(1) reporting as a measure of platelet aggregation the first impedance signal, the second impedance signal, the third impedance signal and/or the mean or median value thereof if no impedance signal is discarded in step (e);

(2) reporting as a measure of platelet aggregation one or more impedance signals of the remaining pair of impedance signals and/or a mean or median value of the remaining pair of impedance signals if the variation of the remaining pair of impedance signals is not determined in step (f) to be higher than the second predetermined threshold; or,

(3) repeating steps (a) through (f) if one of the first impedance signal, the second impedance signal and the third impedance signal was discarded in step (e) and the variation between the remaining pair of impedance signals is determined in step (f) to be above the second predetermined threshold.

2. The method of claim, 1 wherein measuring comprises measuring at least 2 of the first impedance signal, the second impedance signal and the third impedance signal in parallel.

3. The method of claim 1 further comprising adding reagents that either activate or inhibit platelet function to the cup portion of the cartridge device.

4. The method of claim 1 , wherein at least one of the first impedance signal, the second impedance signal and the third impedance signal is a continuous signal that is indicative of the kinetics of platelet aggregation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2016
From: F. HOFFMANN-LA ROCHE AG
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 039502/0759 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2014
From: DYNABYTE-INFORMATIONSSYSTEME GMBH
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 031957/0622 →
Continuity (3)
Division 13029553 · Feb 17, 2011
Division 10583062 · Jan 31, 2007
Related Publication 20140154810A1 · Jun 5, 2014